drugset / Trial / NCT00761358

To Verify the Efficacy of Z-338 in Subjects With Functional Dyspepsia

NCT00761358

Phase 3 Completed 820 enrolled Zeria Pharmaceutical
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to verify the superior efficacy of Z-338 to placebo in subjects with Functional Dyspepsia, focusing on the assessment of subjective symptoms.

Timeline

Start
2008-09
Primary completion
2010-06
Completion
2010-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Acotiamide Small molecule 100 mg Oral

Indications